Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Thromboembolic Risk Assessment in Patients Admitted With Acute Medical Diseases to Conventional and At Home Hospitalization Units (TROMBODOM/ADOMFIB Study)

NCT06110949 is registered in ClinicalTrials.gov with Universidad Pública de Navarra as lead sponsor.

NCT NCT06110949
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06110949 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Thromboembolic Risk Assessment in Patients Admitted With Acute Medical Diseases to Conventional and At Home Hospitalization Units (TROMBODOM/ADOMFIB Study)
Lead sponsor
Universidad Pública de Navarra
Phase
Observational
Overall status
Unknown status
Start date
March 1, 2023
Completion date
March 31, 2025
Enrollment
1,953 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

atrial fibrillation, hospital at home, physical inactivity, thromboembolism, venous, thromboprophylaxis